Cleveland Clinic Lerner College of Medicine
Vinod Labhasetwar, Ph.D., is a Professor in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and a senior staff member of the Department of Biomedical Engineering, Lerner Research Institute, Cleveland The clinic, both in Cleveland, Ohio, USA. He leads Cleveland Clinic’s Cancer NanoMedicine Program, a collaborative effort jointly sponsored by the Department of Biomedical Engineering and the Taussig Cancer Institute. The primary research focus of Dr. Labhasetwar’s laboratory over the past 25+ years has been on nanoparticle-mediated drug delivery in the context of translational and clinical medicine, particularly focusing on disease conditions where no effective treatments yet exist. HIs team’s specific interests are in developing effective approaches to cancer therapy (against drug resistance and metastasis), cardiovascular diseases (particularly inhibition of restenosis), and facilitating neuromuscular repair mechanisms in stroke and spinal cord injury. Recently, his group’s efforts have been expanding into two new areas: retinitis pigmentosa, with the goal of slowing the progression of photoreceptor degeneration; and transplantation research, with the objective of extending the critical window of time for organ preservation. Dr. Labhasetwar has published over 180 peer-reviewed articles and book chapters. He is listed among 2014 and 2015 Highly Cited Researchers by Thomson Reuters, based on the top 1% of citations during the past 10 years. He has over 25 issued the US and international patents and 4 provisional US patents filed/pending. Dr. Labhasetwar is Editor-in-Chief of Drug Delivery and Translational Research, an official journal of the Controlled Release Society. He has received many Distinguished Scientist and Innovator awards and is a Fellow of the American Association of Pharmaceutical Scientists and the Controlled Release Society.
Biomedical Engineering, Cancer NanoMedicine, Drug Delivery, cancer therapy, cardiovascular diseases (particularly inhibition of restenosis), neuromuscular repair mechanisms in stroke and spinal cord injury